Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)

NCT01496573 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01496573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01496573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
May 31, 2016
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar childhood rhabdomyosarcoma, childhood rhabdomyosarcoma, embryonal childhood rhabdomyosarcoma